Glycoprotein IV (GPIIIb, CD36) is a major platelet membrane glycoprotein which is thought to participate in a number of adhesive reactions and to mediate signal transduction. In order to measure the total content of GPIV in human platelets, we have developed a simple and sensitive solid-phase radioimmunoassay based on the immunocapture of GPIV from Triton X-100-solubilized platelets. FA6-152, a monoclonal antibody to GPIV was coated on microtiter plates and bound antigen was quantified with a radiolabeled polyclonal antibody to GPIV Using purified GPIV as a standard, the coefficients of variation of the assay were found to be less than 10% at concentrations of GPIV ranging from 0.15 to 0.75 µg/ml. The assay was validated by the parallelism obtained between purified GPIV dose-response curves and those obtained with platelet lysates, indicating a similar antigenic activity for GPIV in both samples. The level of GPIV in platelets from healthy donors was 0.23 ± 0.05 (mean ± SD, n = 15) µg per 100 µg of platelet proteins and a mean value of 27,440 ± 6,200 (SD) molecules per platelet was calculated. The radioimmunoassay could be used to discriminate between the high level of platelet GPIV in patients with essential thrombocythemia (mean ± SD = 81,850 ± 27,780 molecules/platelet; n = 8) and the normal GPIV level in patients with secondary thrombocytosis (mean ± SD = 26,810 ± 4,030 molecules/platelet; n = 5), thereby demonstrating the clinical usefulness of the assay. The specific increase in platelet GPIV in patients with essential thrombocythemia was confirmed by immunoblot analysis whereas no increase in platelet GPIb or GPIIb-IIIa was observed by this technique.
REFERENCES
1
Clemetson KJ,
Mc Gregor JL.
Characterization of platelet membrane glycoproteins. In: Platelets in Biology and Pathology III.
MacIntyre DE,
Gordon JL.
(eds)
Elsevier Science Publishers BV, Amsterdam: 1987. pp 160-212
4
Kieffer N,
Bettaieb A,
Legrand C,
Coulombel L,
Vainchenker W,
Edelman L,
Breton-Gorius J.
Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor. Biochem J 1989; 262: 835-842
5
Greenwalt DE,
Watt KWK,
So OY,
Jiwani N.
PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GPIV). Biochemistry 1990; 29: 7054-7059
10
Tandon NN,
Kralisz U,
Jamieson GA.
Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583
11
Kieffer N,
Nurden AT,
Hasitz M,
Titeux M,
Breton-Gorius J.
Identification of platelet membrane thrombospondin binding molecules using an anti-thrombospondin antibody. Biochim Biophys Acta 1988; 967: 408-415
12
Beiso P,
Pidard D,
Fournier D,
Dubernard V,
Legrand C.
Studies on the interaction of platelet glycoprotein IIb-IIIa and glycoprotein IV with fibrinogen and thrombospondin: A new immunological approach. Biochim Biophys Acta 1990; 1033: 07-12
16
Kehrel B,
Kronenberg A,
Schwippert B,
Niesing-Bresch D,
Niehues U,
Tschöpe D,
van de Loo J,
Clemetson KJ.
Thrombospondin binds normally to glycoprotein IIIb deficient platelets. Biochem Biophys Res Commun 1991; 179: 985-991
18
Ockenhouse CF,
Magowan C,
Chulay JD.
Activation of monocytes and platelets by monoclonal antibodies or infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest 1989; 84: 468-475
19
Aiken ML,
Ginsberg MH,
Byers-Ward V,
Plow EF.
Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990; 76: 2501-2509
20
Legrand C,
Pidard D,
Beiso P,
Tenza D,
Edelman L.
Interaction of a monoclonal antibody to glycoprotein IV (CD36) with human platelets and its effect on platelet function. Platelets 1991; 2: 099-105
21
Huang MM,
Bolen JB,
Barnwell JW,
Shattil SJ,
Brugge JS.
Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991; 88: 7844-7848
22
Bolin RB,
Okumura T,
Jamieson GA.
Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders. Am J Hematol 1977; 3: 63-71
23
Eche N,
Sie P,
Caranobe C,
Nouvel J,
Pris J,
Boneu B.
Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density. Scand J Haematol 1981; 26: 123-129
24
Clezardin P,
Mc Gregor JL,
Dechavanne M,
Clemetson KJ.
Platelet membrane glycoprotein abnormalities in patients with myeloprolifera tive disorders and secondary thrombocytosis. Br J Haematol 1985; 60: 331-344
25
Legrand C,
Bellucci S,
Disdier M,
Edelman L,
Tobelem G.
Platelet thrombospondin and glycoprotein IV abnormalities in patients with essential thrombocythemia. Effect of α-interferon treatment. Am J Hematol 1991; 38: 307-313
26
Bellucci S,
Janvier M,
Tobelem G,
Flandrin G,
Charpak Y,
Berger R,
Boiron M.
Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 1986; 58: 2440-2447
28
Wicki AN,
Clemetson KJ.
Structure and function of platelet membrane glycoprotein Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985; 153: 01-11
29
Cramer EM,
Savidge GF,
Vainchenker W,
Berndt MC,
Pidard D,
Caen JP,
Massé JM,
Breton-Gorius J.
Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes. Blood 1990; 75: 1220-1227
31
Markwell MAK,
Haas SM,
Lieber LL,
Tolbert NE.
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-210
33
Kieffer N,
Boizard B,
Didry D,
Wautier JL,
Nurden AT.
Immunochemical characterization of the platelet-specific alloantigen Leka. A comparative study with the PLA1 alloantigen. Blood. 1984; 64: 1212-1219
34
Legrand C,
Thibert V,
Dubernard V,
Bégault B,
Lawler J.
Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets. Modulation of platelet aggregation. Blood 1992; 79: 1995-2003
35
Yamazaki H,
Suzuki H,
Yamamoto N,
Baba I,
Arai M,
Fujimaki M,
Tanoue K.
Glycoprotein (GP) IV localizes on plasma membrane including open canalicular system but not alpha-granule membrane. Thromb Haemostas 1991; 65: 1070a
